gradhivne1
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 12, 2025 (NCT06617091)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06617091 | Phase 1 | Feb 12, 2025 | Africa Health Research Institute, Desmond Tutu Health Foundation, International AIDS Vaccine Initiative, Ragon Institute of MGH, MIT and Harvard, ReiThera Srl |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Africa Health Research Institute | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Desmond Tutu Health Foundation | Academic/Hospital | 1 | 0 | 1 | 2025 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Ragon Institute of MGH, MIT and Harvard | Academic/Hospital | 1 | 0 | 1 | 2025 |
| ReiThera Srl | For profit | 1 | 0 | 1 | 2025 |
5 organizations
Page 1 / 1